FDA Law Blog

MARCH 21, 2024

As readers of our blog know, MoCRA was a significant change to regulation of cosmetics. As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.

Cosmetics 64

Cosmetics Production Compliance Regulation 64

Camargo

NOVEMBER 15, 2021

The 21 st Century Cures Act generated a good deal of excitement and interest when it added a section called “ Utilizing Real World Evidence ” to the Food, Drug, and Cosmetic Act (Section 505F). Batch steps include filter drying, milling, and packaging. FDA Guidance Addresses Real-World Evidence Data Standards.

Development 187

Development Manufacturing Production Packaging 187

pharmaphorum

DECEMBER 9, 2021

Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. She has experience in R&D management of new product development, external innovation and OTC, cosmetic and commodity regulatory affairs.

Allergies 105

Allergies Life Science Development Scientist 105

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. An external panel of scientists analyzed the testing results. In its August 16, 2023 decision in Le-Vel Brands, LLC v.

Production 52

Production Cosmetics Regulation Branding 52

XTalks

APRIL 14, 2021

Scientists used synthetic biology and computational protein design tools to develop an enzymatic process to transform red cabbage anthocyanins into their desired color. The US Food and Drug Administration (FDA) defines color additives as “any substance that imparts color to a food, drug, cosmetic, or the human body.

Regulation 94

Regulation Production Branding Research 94

XTalks

AUGUST 2, 2023

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. a month for either 150 mg or 300 mg dose strength packages, and $3,462.13

Sales 98

Sales Manufacturing FDA Approval Life Science 98